The Power to Remake a Species
By Rebecca Boyle,
Future of Life Institute
| 07. 23. 2015
[quotes CGS's Marcy Darnovsky]
In 2013, some 200 million humans suffered from malaria, and an estimated 584,000 of them died, 90 percent in Africa. The vast majority of those killed were children under age 5. Decades of research have fallen short of a vaccine for this scourge. A powerful new technique that allows scientists to selectively edit entire genomes could provide a solution, but it also poses risks—and ethical questions science is only beginning to address.
The technique relies on a tool called a gene drive, something scientists have discussed since 2003 but which has only recently become possible. A gene drive greatly increases the odds that a particular gene will be inherited by all future generations. Genes occasionally evolve the ability naturally, but if we could engineer it deliberately, small interventions could have enormous impact, giving scientists the power to eradicate diseases, remove invasive species, and wholly remake the natural landscape.
One proposed use of a gene drive would alter the genetic code of a few mosquitoes that carry the malaria parasite, ensuring that the ‘Y’ chromosome would always be passed on. The...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...